BioDelivery Sciences (BDSI) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BDSI Hot Sheet
Price: $5.59 --0%
Financial Fact:
General and administrative: 12.05M
Today's EPS Names:
IEP, XPRO, GEF, More
Financial Fact:
General and administrative: 12.05M
Today's EPS Names:
IEP, XPRO, GEF, More
Join SI Premium – FREE
BioDelivery Sciences (NASDAQ: BDSI) reported Q2 EPS of ($0.31), in-line with the analyst estimate of ($0.31). Revenue for the quarter came in at $5 million versus the consensus estimate of $3.35 million.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- California Resources (CRC) Tops Q3 EPS by 21c
- Grifols, S.A. (GRFS) Reports Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
